Brind.
  1. Aurora Cannabis Inc., a company based in Canada, operates globally including Europe with GMP-certified facilities in Germany, and its shares trade on the NASDAQ. Miguel Martin is the Executive Chairman and CEO.

Aurora Cannabis has successfully navigated regulatory challenges and achieved strong performance in key European markets, including developments related to Poland.

2 reports, 2 independent Updated Aug 13
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
5
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Aurora Cannabis has successfully navigated regulatory challenges and achieved strong performance in key European markets, including developments related to Poland.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Aurora Cannabis launched two new products in Poland on June 24, 2025.Sub-event
  2. CanniMed launched high potency medical cannabis products in Poland.Sub-event
  3. Aurora Cannabis's Brampton facility received EU-GMP certification, positioning the company in the international medical cannabis market.Sub-event
  4. Aurora Cannabis's medical cannabis segment saw higher international revenues supported by domestic demand.Sub-event
  5. Aurora Cannabis resolves regulatory headwinds and reports strong performance in key European markets, including Poland.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Exec EdgeIt’s 420 Somewhere: Aurora Cannabis Sparks Up the Top Line – Quarterly Update Report Download the Complete Report Here By Rayk Riechmann Another impressive top-line beat by Aurora Cannabis Inc. (Nasd
  • GuruFocus.comAurora Cannabis Inc (ACB) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... Net Revenue: Increased 17% to $98 million. Global Medical Cannabis Revenue: Rose 37% to $64.8 milli